...
首页> 外文期刊>Journal of receptor and signal transduction research >Differential expression and signaling of the human histamine H-3 receptor isoforms of 445 and 365 amino acids expressed in human neuroblastoma SH-SY5Y cells
【24h】

Differential expression and signaling of the human histamine H-3 receptor isoforms of 445 and 365 amino acids expressed in human neuroblastoma SH-SY5Y cells

机译:人组胺H-3受体同种型445和365氨基酸中的差异表达和信号传导在人神经母细胞瘤SH-SEC5Y细胞中表达

获取原文
获取原文并翻译 | 示例
           

摘要

In stably-transfected human neuroblastoma SH-SY5Y cells, we have compared the effect of activating two isoforms of 445 and 365 amino acids of the human histamine H-3 receptor (hH(3)R(445) and hH(3)R(365)) on [S-35]-GTP gamma S binding, forskolin-induced cAMP formation, depolarization-induced increase in the intracellular concentration of Ca2+ ions ([Ca2+]i) and depolarization-evoked [H-3]-dopamine release. Maximal specific binding (B-max) of [H-3]-N-methyl-histamine to cell membranes was 953 +/- 204 and 555 +/- 140 fmol/mg protein for SH-SY5Y-hH(3)R(445) and SH-SY5Y-hH(3)R(365) cells, respectively, with similar dissociation constants (K-d, 0.86 nM and 0.81 nM). The mRNA of the hH(3)R(365) isoform was 40.9 +/- 7.9% of the hH(3)R(445) isoform. No differences in receptor affinity were found for the H3R ligands histamine, immepip, (R)(-)-alpha-methylhistamine (RAMH), A-331440, clobenpropit and ciproxifan. Both the stimulation of [S-35]-GTP gamma S binding and the inhibition of forskolin-stimulated cAMP accumulation by the agonist RAMH were significantly larger in SH-SY5Y-hH(3)R(445) cells ([S-35]-GTP gamma S binding, 158.1 +/- 7.5% versus 136.5 +/- 3.6% for SH-SY5Y-hH(3)R(365) cells; cAMP accumulation, -74.0 +/- 4.9% versus -43.5 +/- 5.3%), with no significant effect on agonist potency. In contrast, there were no differences in the efficacy and potency of RAMH to inhibit [H-3]-dopamine release evoked by 100 mM K+ (-18.9 +/- 3.0% and -20.5 +/- 3.3%, for SH-SY5Y-hH(3)R(445) and SH-SY5Y-hH(3)R(365) cells), or the inhibition of depolarization-induced increase in [Ca2+]i (S2/S1 ratios: parental cells 0.967 +/- 0.069, SH-SY5Y-hH(3)R(445) cells 0.639 +/- 0.049, SH-SY5Y-hH(3)R(365) cells 0.737 +/- 0.045). These results indicate that in SH-SY5Y cells, hH(3)R(445) and hH(3)R(365) isoforms regulate in a differential manner the signaling pathways triggered by receptor activation.
机译:在稳定转染的人神经母细胞瘤SH-SY5Y细胞中,我们比较了活化两种同种型的445和365个氨基酸的效果(HH(3)R(445)和HH(3)R( 365))在[S-35] --GTPγS结合,Forskolin诱导的阵营形成,Ca 2 +离子细胞内浓度的去极化诱导的增加([Ca2 +] I)和去极化诱发的[H-3] - 二醇释放。 [H-3] -N-甲基 - 组胺的最大特异性结合(B-MAX)至细胞膜为953 +/- 204和555 +/-140 fmol / mg蛋白,用于SH-SY5Y-HH(3)R( 445)和SH-SY5Y-HH(3)r(365)细胞分别具有相似的解离常数(Kd,0.86nm和0.81nm)。 HH(3)R(365)同种型的mRNA为HH(3)R(445)同种型的40.9 +/- 7.9%。对于H3R配体组胺,ImmePIP,(R)( - ) - α-甲基胺(RamH),A-331440,Clobenpropit和Ciproxifan,没有发现受体亲和力的差异。 SH-SY5Y-HH(3)R(3)r(3)r(445)细胞的激动剂Ramh的刺激均刺激γramh抑制的激动剂Ramh的抑制作用显着较大([S-35] -GTPγS绑定,158.1 +/- 7.5%对SH-SY5Y-HH(3)R(365)细胞的136.5 +/- 3.6%;营地积累,-74.0 +/- 4.9% - 43.5 +/- 5.3%),对激动剂效力没有显着影响。相反,ramh抑制抑制的疗效和效力没有差异[H-3] - 浸出诱导100mm k +(-18.9 +/- 3.0%和-20.5 +/- 3.3%,用于SH-SY5Y -HH(3)R(445)和SH-SY5Y-HH(3)R(365)细胞),或抑制[CA2 +] I的去极化诱导的增加(S2 / S1比:亲本细胞0.967 +/- 0.069,SH-SY5Y-HH(3)R(445)细胞0.639 +/- 0.049,SH-SY5Y-HH(3)R(365)细胞0.737 +/- 0.045)。这些结果表明,在SH-SY5Y细胞中,HH(3)R(445)和HH(3)R(365)同种型以差异方式调节,通过受体激活触发的信号传导途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号